Pooled analysis of two phase III studies provides prognostic indicators for clinical outcome after catumaxomab treatment for malignant ascites

被引：0
|
作者：
Bokemeyer, C. [1 ]
Heiss, M. M. [2 ]
Lordick, F. [3 ]
Parsons, S. L. [4 ]
Wimberger, P. [5 ]
Friccius-Quecke, H. [6 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[2] Univ Witten Herdecke, Krankenhaus Koln Merheim, Cologne, Germany
[3] Univ Klinikum, Leipzig, Germany
[4] Nottingham Univ Hosp NHS Trust, Nottingham, England
[5] Tech Univ Dresden, D-01062 Dresden, Germany
[6] Fresenius Biotech GmbH, Munich, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [41] Secukinumab Provides Rapid and Sustained Resolution of Enthesitis in Psoriatic Arthritis Patients: Pooled Analysis of Two Phase 3 Studies
    Coates, Laura C.
    McGonagle, Dennis
    Schett, Georg
    Mease, Philip J.
    Quebe-Fehling, Erhard
    Asquith, D. L.
    Rasouliyan, L.
    Mpofu, Shephard
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies
    Ferrero, JM
    BULLETIN DU CANCER, 2005, 92 (05) : 425 - 427
  • [43] Adjuvant Cerepro® treatment of patients with operable glioblastoma multiforme -: a pooled analysis of two clinical studies
    Sandmair, Anu-Maaria
    Yla-Herttuala, Seppo
    Langford, Gillian
    Murray, Neil
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (02) : 210 - 210
  • [44] Performance Of The Exacerbations Of Chronic Pulmonary Disease Tool-Respiratory Symptoms Diary In Clinical Trials: Pooled Analysis Of Two Phase Iii Studies
    Leidy, N. K.
    Jones, P. W.
    Hareendran, A.
    Lamarca, R.
    Chuecos, F.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [45] Safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: Analysis of pooled phase III studies
    Ferreira, J.
    Lees, A.
    Gama, H.
    Lopes, N.
    Santos, A.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
  • [46] Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
    Steinhoff, Bernhard J.
    Ben-Menachem, Elinor
    Ryvlin, Philippe
    Shorvon, Simon
    Kramer, Lynn
    Satlin, Andrew
    Squillacote, David
    Yang, Haichen
    Zhu, Jin
    Laurenza, Antonio
    EPILEPSIA, 2013, 54 (08) : 1481 - 1489
  • [47] Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis on the head and neck: Pooled analysis of phase III studies
    Kircik, Leon
    JosephFowler
    Weiss, Jonathan
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB252 - AB252
  • [48] Comparative analysis of the outcome of two phase III studies of interferon beta-1b
    McFarland, HF
    NEUROLOGY, 2000, 54 (12) : 2352 - 2352
  • [49] Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies
    Hurwitz, Herbert I.
    Douglas, Pamela S.
    Middleton, John P.
    Sledge, George W.
    Johnson, David H.
    Reardon, David A.
    Chen, Dafeng
    Rosen, Oliver
    ONCOLOGIST, 2013, 18 (03): : 273 - 280
  • [50] ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS
    Khullar, V
    Nitti, V
    Dmochowski, R.
    Sand, P.
    Chapple, C.
    Sievert, K.
    MacDiarmid, S.
    Radziszewski, P.
    Nardo, C.
    Zhou, J.
    Haag-Molkenteller, C.
    Herschorn, S.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 765 - 765
12345